Howard Leslie Levine

Title: Howard Leslie Levine: Innovator in Progesterone Delivery

Introduction

Howard Leslie Levine is an inventor based in the United States, known for his contributions to the field of hormone delivery systems. His innovative approach focuses on the delivery of progesterone, which has significant implications for women's health.

Latest Patents

Levine's notable patent is titled "Novel Method Of Progesterone Delivery And Affect Thereof." This invention teaches that relatively low levels of serum progesterone, specifically between 1 to 6 ng/ml, can be utilized to prevent endometrial cancer. The method involves the vaginal delivery of progesterone using a cross-linked polycarboxylic polymer, which achieves the desired low serum progesterone levels while ensuring the full secretory transformation of the endometrium. This approach indicates the efficacy of progesterone in reducing the risk of breast cancer for women undergoing hormone replacement therapy (HRT) and minimizes potential undesirable side effects associated with progesterone.

Career Highlights

Howard Leslie Levine is associated with Columbia Laboratories, Inc., where he has been instrumental in advancing research related to hormone delivery systems. His work has contributed to a better understanding of how progesterone can be effectively delivered to improve women's health outcomes.

Collaborations

Levine has collaborated with William Joseph Bologna, who is also involved in the field of hormone delivery and research. Their partnership has fostered advancements in the understanding and application of progesterone therapy.

Conclusion

Howard Leslie Levine's innovative work in progesterone delivery represents a significant advancement in women's health. His contributions have the potential to improve treatment options and reduce health risks associated with hormone replacement therapy.